Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular versus intravenous ketamine for pediatric procedural sedation
ACTRN12619000612112Phase 4Recruiting
- Sponsor
- Gold Coast Hospital and Health Service
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ketamine in procedural sedation and analgesia (PSA) (3 arms), sponsored by Gold Coast Hospital and Health Service. Primary endpoint: Successful procedural sedation with only one needle. Started Jul 2019; status: recruiting.
02
Drugs
ketamine
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on ACTRN12619000612112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000612112.